Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ePoster Display

808P - Characteristics and outcomes of women with adenocarcinoma versus squamous cell carcinoma of the vulva: A Japanese Gynecologic Oncology Group study

Date

16 Sep 2021

Session

ePoster Display

Topics

Surgical Oncology;  Rare Cancers

Tumour Site

Vulvar and Vaginal Cancers

Presenters

Shin Nishio

Citation

Annals of Oncology (2021) 32 (suppl_5): S725-S772. 10.1016/annonc/annonc703

Authors

S. Nishio1, K. Matsuo2, S. Matsuzaki2, T. Kato3, S. Kamiura4, H. Adachi5, M. Okadome6, T. Nakamura7, M. Mikami8, T. Enomoto9

Author affiliations

  • 1 Obstetrics And Gynecology, Kurume University, 830-0011 - Kurume/JP
  • 2 Obstetrics And Gynecology, University of Southern California, Los Angeles/US
  • 3 Gynecogic Oncology, National Cancer Center Hospital, 104-0045 - Tokyo/JP
  • 4 Gynecology, Osaka International Cancer Institute, Osaka/JP
  • 5 Gynecology, Seirei Hamamatsu General Hospital, Hamamatsu/JP
  • 6 Gynecology Service, National Hospital Organization Kyushu Cancer Center, Fukuoka/JP
  • 7 Obstetrics And Gynecology, Kagoshima City Hospital, Kagoshima/JP
  • 8 Obstetrics And Gynecology, Tokai University Hospital, Isehara/JP
  • 9 Obstetrics And Gynecology, Niigata University School of Medicine, Niigata/JP

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 808P

Background

Studies on vulvar adenocarcinoma are lacking. Thus, we aimed to compare the characteristics and survival outcomes between vulvar adenocarcinoma and squamous cell carcinoma (SCC).

Methods

This was a preplanned sub-analysis of a previously organized nationwide retrospective observational study in Japan conducted between 2001 and 2010 (JGOG-1075S). Surgically treated women with stage I-IV vulvar invasive adenocarcinoma were compared to those with SCC. Multivariable analysis was performed to identify patient and tumor characteristics related to adenocarcinoma. Inverse probability of treatment weighting was used to balance the background differences, and a Cox proportional hazards regression model was fitted to estimate the effect of the histological type on survival.

Results

Forty-eight women with adenocarcinoma were compared with 537 women with SCC. On multivariable analysis, women with adenocarcinoma were younger (median age, 64.5 vs. 70 years, adjusted odds ratio [OR] per age 0.975, 95% confidence interval [CI] 0.955-0.995, P=0.016) and had higher positive surgical margin rates (31.2% vs. 18.4%, adjusted OR 2.376, 95% CI 1.188-4.754, P=0.014) than those with SCC. However, according to the weighted model, the survival outcomes were comparable (hazard ratio for progression-free survival, 1.088, 95% CI 0.740-1.601, P=0.667 and hazard ratio for overall survival, 1.008, 95% CI 0.646-1.573, P=0.973). Similar associations were observed when the cohort was stratified by age (≤70 or >70 years), stage (I-II or III-IV), and surgical margin (negative or positive) (all, P>0.05).

Conclusions

Vulvar adenocarcinoma is characterized by a younger age at diagnosis and higher positive surgical margin rates than SCC, but the survival outcomes are comparable.

Clinical trial identification

UMIN000017080.

Editorial acknowledgement

Legal entity responsible for the study

The authors.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.